LifeStance Health Group Sees Unusually High Options Volume (NASDAQ:LFST)

LifeStance Health Group, Inc. (NASDAQ:LFST) was the target of unusually large options trading activity on Monday. Investors purchased 3,293 call options on the company. This represents an increase of approximately 655% compared to the average daily volume of 436 call options.

Wall Street Analyst Weigh In

LFST has been the subject of a number of recent analyst reports. Barclays lowered their price target on LifeStance Health Group from $8.00 to $6.00 and set an “underweight” rating for the company in a research note on Friday, August 9th. UBS Group lowered their price objective on shares of LifeStance Health Group from $9.00 to $7.50 and set a “neutral” rating for the company in a research report on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $8.25.

Insider Buying and Selling

In related news, insider Kevin Michael Mullins sold 85,093 shares of the stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $5.53, for a total transaction of $470,564.29. Following the sale, the insider now directly owns 4,650,571 shares in the company, valued at approximately $25,717,657.63. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other LifeStance Health Group news, insider Kevin Michael Mullins sold 85,093 shares of the business’s stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $5.53, for a total value of $470,564.29. Following the completion of the transaction, the insider now directly owns 4,650,571 shares of the company’s stock, valued at $25,717,657.63. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Danish J. Qureshi sold 150,000 shares of the business’s stock in a transaction that occurred on Friday, June 14th. The stock was sold at an average price of $5.21, for a total transaction of $781,500.00. Following the completion of the transaction, the insider now owns 439,002 shares of the company’s stock, valued at approximately $2,287,200.42. The disclosure for this sale can be found here. 6.60% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of LFST. Vanguard Group Inc. boosted its holdings in shares of LifeStance Health Group by 1.3% during the first quarter. Vanguard Group Inc. now owns 7,668,966 shares of the company’s stock worth $47,318,000 after acquiring an additional 95,197 shares during the period. Brown Advisory Inc. increased its position in LifeStance Health Group by 25.9% during the 4th quarter. Brown Advisory Inc. now owns 5,158,980 shares of the company’s stock worth $40,395,000 after buying an additional 1,062,887 shares during the period. Principal Financial Group Inc. lifted its holdings in shares of LifeStance Health Group by 2.8% during the fourth quarter. Principal Financial Group Inc. now owns 4,006,344 shares of the company’s stock worth $31,370,000 after buying an additional 110,457 shares in the last quarter. Jennison Associates LLC boosted its position in shares of LifeStance Health Group by 0.7% in the first quarter. Jennison Associates LLC now owns 1,938,323 shares of the company’s stock valued at $11,959,000 after acquiring an additional 12,629 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in shares of LifeStance Health Group by 82.0% in the second quarter. Dimensional Fund Advisors LP now owns 1,016,452 shares of the company’s stock valued at $4,991,000 after acquiring an additional 457,930 shares in the last quarter. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Stock Performance

LifeStance Health Group stock traded up $0.30 during midday trading on Monday, reaching $6.48. 1,122,753 shares of the company’s stock were exchanged, compared to its average volume of 1,514,626. The stock’s 50-day simple moving average is $5.44 and its 200 day simple moving average is $6.06. The firm has a market cap of $2.48 billion, a price-to-earnings ratio of -13.71 and a beta of 1.20. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.18 and a current ratio of 1.18. LifeStance Health Group has a 52 week low of $4.64 and a 52 week high of $9.20.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.01. LifeStance Health Group had a negative return on equity of 11.92% and a negative net margin of 15.69%. The business had revenue of $312.30 million during the quarter, compared to the consensus estimate of $305.85 million. During the same quarter last year, the firm posted ($0.13) EPS. The company’s quarterly revenue was up 20.3% on a year-over-year basis. On average, analysts expect that LifeStance Health Group will post -0.25 earnings per share for the current fiscal year.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.